Carregant...
Pan-caspase inhibitor F573 mitigates liver ischemia reperfusion injury in a murine model
BACKGROUND: Liver ischemia reperfusion injury (IRI) remains a challenge in liver transplantation. A number of compounds have previously demonstrated efficacy in mitigating IRI. Herein, we applied three specific additive strategies to a mouse IRI screening model to determine their relative potencies...
Guardat en:
| Publicat a: | PLoS One |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Public Library of Science
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6879152/ https://ncbi.nlm.nih.gov/pubmed/31770375 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0224567 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|